2000; 343:896. 321. Ciof G, Stefenelli C, Tarantini L, et al. Hemodynamic response to intensive unloading therapy (furosemide and nitroprusside) in patients >70 years of age with left ventricular systolic dysfunction and decom- pensated chronic heart failure. Am J Cardiol 2003;92:1050 6. 322. O Connor CM, Starling RC, Hernandez AF, et al. Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med 2011; 365:32 43. 323. Publication Committee for the VMAC Investigators. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA. 2002;287:1531 40. Erratum in: JAMA. 2002;288:577. 324. Alikhan R, Cohen AT, Combe S, et al. Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study. Blood Coagul Fibrinolysis 2003; 14:341 6. 325. Belch JJ, Lowe GD, Ward AG, et al. Prevention of deep vein thrombosis in medical patients by low-dose heparin. Scott Med J 1981; 26:115 7. 326. Kleber FX, Witt C, Vogel G, et al. Randomized comparison of enox- aparin with unfractionated heparin for the prevention of venous throm- boembolism in medical patients with heart failure or severe respiratory disease. Am Heart J 2003;145:614 21. 327. Samama MM, Cohen AT, Darmon JY, et al., Prophylaxis in Medical Patients with Enoxaparin Study Group. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. N Engl J Med 1999;341:793 800. 328. Turpie AG. Thrombosis prophylaxis in the acutely ill medical patient: insights from the prophylaxis in MEDical patients with ENOXaparin (MEDENOX) trial. Am J Cardiol 2000;86:48M 52M. 329. Deleted in press. 330. Ghali JK, Koren MJ, Taylor JR, et al. 